VA tests 'Nudge' to boost lifesaving heart failure prescriptions

NCT ID NCT05986695

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether simple nudges—like an alert in a doctor's daily task list or an email comparing their prescribing habits to peers—could increase the use of two types of heart failure medications (SGLT2 inhibitors and MRAs) that are proven to save lives but are often underused. Researchers enrolled 81 primary care and cardiology clinicians at a single VA hospital. The goal was to see if these gentle reminders could help more eligible veterans get the right prescriptions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
behavioral intervention (informational alert and peer comparison report)
What this could lead to
If successful, this approach could increase use of proven heart failure medications, potentially reducing hospitalizations and saving lives among veterans.
What could go wrong
This is a small, early implementation study with only 81 clinicians at one VA site, so results may not apply broadly. The intervention is a nudge, not a new drug, so its impact may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Southern Arizona VA Health Care System, Tucson, AZ

    Tucson, Arizona, 85723-0001, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.